Improper disposition of medical records appears to be an international problem.  The Saskatchewan Information and Privacy Officer recently issued regulatory guidance to health care providers on complying with the province’s health data protection law.  The guidance is being sent to all health regulatory bodies and health care organization privacy boards in Saskatchewan to remind them of their obligations under the Health Information Protection Act (HIPAA), which was enacted in 1999 and took effect Sept. 1, 2003.  The guidance was prompted in part by an incident where thousands of patient records were dumped in a recycling bin in the provincial capital of Regina. 

The guidance noted that “[e]lectronic medical records may largely eliminate the prospect of patient files blowing in the wind around dumpsters but pose other significant privacy risks. These include snooping, viewing of personal health information without any appropriate need to know, gossip, and carelessness.”

Among the recommendations in the guidance are the following:

  • Designate a Privacy Officer with specific responsibility for compliance with privacy laws and the safe retention and disposition of personal health information.
  • Adopt written policies and procedures, “including physical, administrative and technical measures reasonable for the protection of personal health information.”
  • Adopt and follow a record retention and disposition schedule.
  • Ensure that all personal health information is properly and safely stored at all times.
  • Ensure that when disposing of personal health information all materials are shredded or otherwise completely destroyed.
  • Enter into an appropriate agreement with any entity to which the storage or destruction of patient files is outsourced.

Sound advice for those maintaining personal health information, no matter where they are located.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Anna D. Kraus Anna D. Kraus

Anna Durand Kraus advises on issues relating to the complex array of laws governing the health care industry. Her background as Deputy General Counsel to the U.S. Department of Health and Human Services (“HHS”) gives her broad experience with, and valuable insight into…

Anna Durand Kraus advises on issues relating to the complex array of laws governing the health care industry. Her background as Deputy General Counsel to the U.S. Department of Health and Human Services (“HHS”) gives her broad experience with, and valuable insight into, the programs and issues within the purview of HHS, including Medicare, Medicaid, fraud and abuse, and HIPAA privacy and security. Anna is co-chair of the firm’s Health Care Industry practice group.

Anna regularly advises clients on Medicare reimbursement matters, particularly those arising under Part B and the Part D prescription drug benefit. She also has extensive experience with the Medicaid Drug Rebate program. She assists numerous pharmaceutical and device manufacturers, health care providers, pharmacy benefit managers, and other health care industry stakeholders to navigate the challenges and opportunities presented by the Affordable Care Act.

Anna is a trusted adviser on health information privacy, security and breach notification issues, including those arising under the Health Insurance Portability and Accountability Act (“HIPAA”) and the Health Information Technology for Economic and Clinical Health (“HITECH”) Act. Her background in this area dates back to the issuance of the original HIPAA privacy regulations.

Anna’s clients depend on her to guide them through compliance with the Anti-Kickback statute, the Stark regulations, and other laws preventing fraud and abuse in the health care industry. Her deep knowledge of these laws has made her an important component of the firm’s representation of pharmaceutical companies and health care organizations under federal investigation or facing allegations under the False Claims Act. In addition, clients contemplating acquisitions in the health care sector rely on her to guide due diligence efforts.